HS

Halemane Santhosh

Active Director Director DIN 11125003
DIN 11125003 First appointment May 2025
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value •••• Premium profile

About Halemane Santhosh

Data last updated:

Halemane Santhosh is a Director at Cutisculpt Healthcare Private Limited (since 2025). Cutisculpt Healthcare Private Limited reported revenue of ₹30.1 Lakh (FY 2025).

DIN 11125003
Primary Designation Director
First Appointment 26 May 2025
Oldest Company Age 2 yrs
Largest company Cutisculpt Healthcare Private Limited · ₹30.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 May 20252024₹30.1 Lakh (FY 2025)Active

Board colleagues of Halemane Santhosh

NameDINCompanyDesignation
Chinnapal Thimmappa Hema11124888Cutisculpt Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cutisculpt Healthcare Private Limited
Premium access

Shareholding and investment profile for Halemane Santhosh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Halemane Santhosh

Halemane Santhosh currently holds 1 directorship: Cutisculpt Healthcare Private Limited (Director, since 26 May 2025, revenue ₹30.1 Lakh (FY 2025)).

Halemane Santhosh was first appointed on 26 May 2025 as Director at Cutisculpt Healthcare Private Limited.

The current boards of Halemane Santhosh's companies include Chinnapal Thimmappa Hema (Cutisculpt Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available